Rodrigo do Nascimento Marano Carneiro

CV Lattes ORCID

Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Rodrigo do Nascimento Marano Carneiro in research grants and scholarships supported by FAPESP.

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Ongoing (most recent)

Abstract
Antiplatelet therapy plays a fundamental role in preventing thromboembolic events in patients with coronary artery disease (CAD). Clopidogrel is commonly used as an antiplatelet agent. Edoxaban, a direct-acting oral anticoagulant, has demonstrated efficacy in reducing thromboembolic events in various clinical contexts. However, it remains unclear whether the addition of edoxaban to clopid…
Comparison of platelet aggregation evaluated by Multiplate-TRAP after 10 ± 2 days of edoxaban and clopidogrel versus clopidogrel alone in patients with coronary artery disease., BP.IC

Virtual Library in numbers * Updated data on July 26, 2025

Total / Available in English

1 / 1	Ongoing scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

José Carlos Nicolau

Keywords used by the researcher

Health Sciences Medicine

Please report errors on the page using this form.

Short URL

Abstract